tasimelteon

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago